NFKB1 and metabolic dysfunction-associated steatotic liver disease: There are 138 potential gene targets of S. chinensis for the treatment of ALD, and the pathways involved PI3K-Akt signaling pathway, TNF signaling pathway, non-alcoholic fatty liver disease, and nuclear factor kappa-B (NF-κB) signaling pathway.